Retroviral vectors for HIV immunotherapy

Ann N Y Acad Sci. 1995 Nov 27:772:105-16. doi: 10.1111/j.1749-6632.1995.tb44736.x.
No abstract available

Publication types

  • Review

MeSH terms

  • AIDS Vaccines / administration & dosage
  • AIDS Vaccines / adverse effects
  • AIDS Vaccines / therapeutic use*
  • Animals
  • Cells, Cultured
  • Clinical Trials, Phase I as Topic
  • Female
  • Gene Products, env / genetics
  • Gene Products, env / immunology*
  • Gene Products, rev / genetics
  • Gene Products, rev / immunology*
  • Genetic Therapy* / adverse effects
  • Genetic Vectors*
  • HIV Antibodies / biosynthesis*
  • HIV Infections / therapy*
  • HIV-1 / genetics*
  • HIV-1 / immunology
  • Humans
  • Immunotherapy, Active* / adverse effects
  • Injections, Intramuscular
  • Macaca mulatta
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Papio
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / immunology*
  • Retroviridae / genetics*
  • Safety
  • T-Lymphocytes, Cytotoxic / immunology*
  • Vaccines, Synthetic / administration & dosage
  • Vaccines, Synthetic / adverse effects
  • Vaccines, Synthetic / therapeutic use*
  • rev Gene Products, Human Immunodeficiency Virus

Substances

  • AIDS Vaccines
  • Gene Products, env
  • Gene Products, rev
  • HIV Antibodies
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic
  • rev Gene Products, Human Immunodeficiency Virus